Relapsed/Refractory Mantle Cell Lymphoma

Explore clinical trials studying Relapsed/Refractory Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

6 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed/Refractory Mantle Cell Lymphoma trial results

Completed

NCT01838434

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University of Chicago Chicago, Illinois, United States

Washington University School of Medicine St Louis, Missouri, United States

Roswell Park Cancer Institute Buffalo, New York, United States

Ohio State University Medical Center Columbus, Ohio, United States

Completed

NCT02601313

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Banner MD Anderson Gilbert, Arizona, United States

City of Hope Duarte, California, United States

University California Los Angeles (UCLA) Santa Monica, California, United States

Stanford University Stanford, California, United States

View all 32 locations

Completed

NCT04880434

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Stanford University Palo Alto, California, United States

University California Los Angeles (UCLA) Santa Monica, California, United States

Sarah Cannon- Denver Denver, Colorado, United States

View all 40 locations

Completed

NCT03886831

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Anemia, +39 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

UCSF Precision Cancer Medicine Building San Francisco, California, United States

Christiana Care Health Services, Christiana Hospital Newark, Delaware, United States

Florida Cancer Specialists Lake Mary, Florida, United States

View all 23 locations

Completed

NCT02460276

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Rigshospitalet Copenhagen, Denmark

Helsinki University Hospital Helsinki, Finland

Norwegian Radium Hospital Oslo, Norway

Lund University Hospital Lund, Sweden

Active, Not Recruiting

NCT06253663

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Chiba University Hospital Chiba, Japan

Kyushu University Hospital Fukuoka, Japan

Hokkaido University Hospital Hokkaido, Japan

Kyoto University Hospital Kyoto, Japan